Company: XOMAP
Filing Date: 2025-08-18
Form Type: SC TO-T
Source: 0001193125-25-182241
Chunk: 4

Company: XOMA Royalty Corp
Filing Date: 2025-08-18
Form: SC TO-T
Chunk 4
---
 1. Terms of the Offer” and “The Tender Offer—Section 7. Summary of the Merger Agreement and Certain Other Agreements” of the Offer to Purchase is incorporated herein by reference.

| ITEM 7. | SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. |

(a), (d) The information set forth in the section of the Offer to Purchase titled “Summary Term Sheet” and in “The Tender Offer—Section 8. Source and Amount of Funds” of the Offer to Purchase is incorporated herein by reference. (b) The Offer is not subject to a financing condition.

| ITEM 8. | INTEREST IN SECURITIES OF THE SUBJECT COMPANY. |

The information set forth in “Special Factors—Section 2. Purpose of the Offer and Plans for HilleVax,” “The Tender Offer—Section 6. Certain Information Concerning Purchasers” and “Schedule A—Information Concerning Members of the Boards of Directors and the Executive Officers of Purchasers” of the Offer to Purchase and “Item 3—Identity and Background of the Filing Persons” hereof is incorporated herein by reference.

| ITEM 9. | PERSONS/ASSETS RETAINED, EMPLOYED, COMPENSATED OR USED. |

(a) The information set forth in the section of the Offer to Purchase titled “Introduction” and in “Special Factors—Section 1. Background of the Offer; Contacts with HilleVax,” “The Tender Offer—Section 3. Procedures for Tendering Shares” and “The Tender Offer—Section 12. Fees and Expenses” of the Offer to Purchase is incorporated herein by reference.

| ITEM 10. | FINANCIAL STATEMENTS. |

Not applicable. Pursuant to Instruction 2 to Item 10 of Schedule TO, Purchasers’ financial statements are not considered material because (i) the consideration offered consists solely of cash, (ii) the Offer is not subject to any financing condition and (iii) Parent is a public reporting company under Section 13(a) or 15(d) of the Act that files reports electronically on EDGAR.

| ITEM 11. | ADDITIONAL INFORMATION. |

(a) The information set forth in “Special Factors—Section 1. Background of the Offer; Contacts with HilleVax,” “Special Factors—Section 2. Purpose of the Offer and Plans for HilleVax,” “Special Factors—Section 4. Possible Effects of the Offer